跳至主要内容
临床试验/ISRCTN86065299
ISRCTN86065299已完成不适用

The effect of a disease-specific supplement on the postprandial plasma glucose response in type 2 diabetic patients at baseline and after 6 and 12 weeks of supplementatio

umico Research B.V. (The Netherlands)0 个研究点目标入组 34 人开始时间: 2006年6月7日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
34

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Diagnosis type 2 diabetes
  • 2. Age >18
  • 3. HbA1c between 6.5% - 8.5%
  • 4. Anti-diabetic therapy: metformin and/or sulfonylureas
  • 5. In need of nutritional support
  • 6. Capable of using oral drink feed supplementation
  • 7. On a stable and controlled anti-diabetic regime for at least one month
  • 8. Signed informed consent

排除标准

  • 1. Pregnant or lactating woman or woman planning to become pregnant
  • 2. Usage of a disease-specific nutritional supplement within past four weeks
  • 5. Concomitant therapy with systemic glucocorticoids, insulin or anti-diabetic medication other than metformin or sulfonylureas
  • 6. Any acute gastrointestinal disease within two weeks prior to study entry
  • 7. Gastrectomy, gastroparesis or other gastric emptying abnormalities
  • 8. Acute severe heart failure, end stage liver failure or renal failure requiring dialysis
  • 9. Patients receiving enteral nutrition
  • 10. Patients with galactosaemia, fructosaemia or patients requiring a fibre-free diet
  • 11. Drug or alcohol abuse
  • 12. Participation in other trials within 4 weeks of study entry

研究者

发起方
umico Research B.V. (The Netherlands)

相似试验